[Iatrogenic gynecomastia in aldosterone-antagonist therapy].
In casuistic form is reported on a patient with double-sided painful gynaecomasty and development of a node in the right breast under therapy with aldosterone antagonists. In this case the pathogenetic factors in the development of spironolactone-induced gynaecomasties are discussed. After a longer application of spironolactone must be reckoned with a gynaecomasty particularly when chronic liver diseases exist.
D001943:Breast Neoplasms / Q000139:chemically induced; D006177:Gynecomastia / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008875:Middle Aged; D013148:Spironolactone / Q000009:adverse effects*
D013148:Spironolactone
Iatrogene Gynäkomastie unter Therapie mit Aldosteronantagonisten.